LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Nano-Based Sensor Technologies Could Make It Possible to Detect COVID-19 at Any Disease Stage, Say Researchers

By LabMedica International staff writers
Posted on 02 Dec 2020
Image: Various diagnostic techniques can be used for sensing the RNA of SARS-CoV-2 (Photo courtesy of Saadet Alpdagtas and Elif Ilhan)
Image: Various diagnostic techniques can be used for sensing the RNA of SARS-CoV-2 (Photo courtesy of Saadet Alpdagtas and Elif Ilhan)
Despite various diagnostic techniques for COVID-19, no single test is available for the entire stage of the disease, although nano-based sensor technologies could make it possible to detect the attack at any stage of the disease, according to researchers.

Researchers at the Van Yuzuncu Yil University (Van, Turkey) along with their colleagues evaluated the available diagnostic techniques for COVID-19 and determined the key steps required for better testing moving forward. Laboratory tests that target the virus's genes - known as real-time reverse transcription-polymerase chain reaction assays - are currently the gold standard for testing. But according to the US Food and Drug Administration (FDA), these tests could give false negatives. These tests depend on the presence of antibodies, which may not have yet been developed in the early stages of infection. Since different antibodies appear at different stages, diagnostic tests must be chosen to target the appropriate immune response based on when an individual is believed to have been infected.

"There is not any available single test for the entire stage of the disease," said Oguzhan Gunduz, one of the researchers. "However, I think it may be possible to detect the attack at any stage of the disease with nano-based sensor technologies."

The researchers have emphasized point-of-care testing as an urgent objective. These types of tests would help detect the virus on site without the need for laboratory equipment or specialized personnel, eliminating or reducing the wait time between testing and obtaining results

"A quite sensitive test that can measure the existent tiny number of viral particles, or any parameter related to the particle - weight, structure, charge, diameter - can provide rapid and early diagnosis," said Gunduz.

When asked about the potential for a more comfortable testing method, Gunduz stressed that this depends on the sampling method and its sensitivity. A fingertip blood test or a saliva test could potentially be underway, though these have their own drawbacks.

"There are such tests, but they come up with accuracy and specificity issues," added Gunduz.

Related Links:
Van Yuzuncu Yil University

Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Gold Member
Immunochromatographic Assay
CRYPTO Cassette

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more